Medical Science Liaison, Molecular Imaging (Cardiac Amyloidosis) - South Central

Bayer•Winters, TX

7d•$168,500 - $252,800•Remote

About The Position

Bayer is seeking a field-based Medical Science Liaison to serve as a credible scientific partner to healthcare professionals across the South Central U.S. territory (Texas, Louisiana, and Missouri). The role focuses on Molecular Imaging and cardiac amyloidosis while supporting compliant scientific exchange across the multidisciplinary amyloidosis ecosystem, including cardiology, hematology/oncology, nuclear medicine, radiology, and integrated amyloidosis centers. Candidates must reside within the territory. The MSL builds peer-to-peer scientific relationships, generates actionable field insights, advances understanding of systemic and cardiac amyloidosis and its diagnostic pathway, supports evidence-generation activities, and contributes to launch-related field capability and institutional readiness. This is a field-execution role centered on scientific engagement, insight generation, and cross-functional follow-through.

Requirements

Advanced clinical or scientific degree, such as PharmD, PhD, MD, DO, DNP, MSN, NP, or PA.
Field-based MSL experience in the pharmaceutical or biotechnology industry.
Ability to critically evaluate and communicate complex clinical and scientific data to expert audiences.
Working knowledge of U.S. compliance requirements governing scientific exchange.
Strong presentation, relationship-building, territory-management, insight-generation, and self-management skills in a remote field role.
Valid driver's license with a clean driving record.
Residence within the assigned territory near a major airport.
Ability to travel 50–70%, including overnight travel and occasional weekends.

Nice To Haves

Field-medical or clinical experience in cardiology, heart failure, cardiomyopathy, cardiac imaging, or cardiac amyloidosis.
At least 3 years of field-based MSL industry experience.
Established scientific relationships in the territory with relevant specialists, amyloidosis centers, or multidisciplinary amyloidosis teams.
Experience supporting a pre-launch or launch-stage product, particularly in a first-in-class, diagnostic, molecular-imaging, or radiopharmaceutical environment.
Working knowledge of systemic amyloidosis, including ATTR and AL pathways, and the roles of imaging, laboratory assessment, biopsy, specialist referral, and multidisciplinary care.
Experience gathering actionable insights, mapping diagnostic or referral pathways, and supporting evidence-generation or investigator-initiated research programs.
Experience collaborating across Medical Affairs, Clinical Development, HEOR/RWE, Market Access, Regulatory, Medical Information, and technical field functions.
Familiarity with CRM and insight-capture platforms such as Veeva.

Responsibilities

Identify, develop, and maintain compliant scientific relationships with cardiologists, heart-failure specialists, hematologists/oncologists, nuclear medicine physicians, radiologists, amyloidosis-center leaders, and other relevant stakeholders.
Conduct balanced, peer-to-peer scientific exchange on systemic and cardiac amyloidosis, diagnostic pathways, clinical evidence, and investigational data in accordance with applicable policies and regulations.
Deliver scientific presentations and disease-state education to healthcare professional and institutional audiences using approved resources.
Execute a territory engagement plan prioritizing relationship depth, multidisciplinary institutional reach, and meaningful follow-up.
Gather, document, and communicate insights about diagnostic and referral pathways, evidence gaps, educational needs, operational readiness, access themes, and barriers to adoption.
Translate field observations into insights that inform Medical strategy, educational planning, evidence priorities, launch preparedness, and cross-functional action.
Map diagnostic pathways and key decision points at priority institutions, including the roles of referring clinicians, imagers, readers, technologists, and multidisciplinary care teams.
Document engagements, insights, follow-up, and territory-plan progress using approved systems.
Advance scientific understanding of systemic and cardiac amyloidosis, including unmet needs related to underdiagnosis, delayed diagnosis, and complex referral pathways.
Identify institution-specific educational needs and support approved disease-state initiatives, advisory boards, congress activities, and other Medical Affairs programs.
Engage stakeholders across cardiology, hematology/oncology, nuclear medicine, and radiology to understand patient pathways from suspicion and referral through imaging, diagnosis, and follow-up.
Support Bayer-sponsored research activities, including investigator and site engagement, site identification, and scientific follow-up, as appropriate.
Identify and appropriately triage investigator-initiated research concepts and evidence gaps through established Medical Affairs processes.
Contribute to assigned evidence-generation, publication, congress, medical-resource, and advisory-board workstreams, with clear documentation and follow-through.
Assess priority-center readiness and identify gaps in referral pathways, scientific understanding, readers, technologists, workflow, or infrastructure.
Route readiness gaps to the accountable function and monitor follow-up through approved processes.
Collaborate with Molecular Imaging Specialists and other authorized partners while maintaining role boundaries; the MSL is accountable for scientific exchange and medical strategy, while technical protocol implementation and scanner-specific execution remain with designated technical roles.
Collaborate with Medical Information, Medical Communications, HEOR/RWE, Commercial, Clinical Development, Regulatory Affairs, Market Access, and other cross-functional partners in compliance with Bayer policies and applicable requirements.
Support internal scientific training on disease state, diagnostic pathways, and clinical evidence as requested.
Complete required trainings and certifications, use approved materials and systems, promptly escalate compliance questions, and conduct activities in accordance with Bayer policies, FDA requirements, OIG guidance, the PhRMA Code, and applicable laws.